Clinical Trials Logo

Filter by:
NCT ID: NCT05856396 Not yet recruiting - Pertussis Clinical Trials

Maternal Determinants of Infant Immunity to Pertussis

MADI-02
Start date: June 1, 2023
Phase: Phase 4
Study type: Interventional

The overall objective of the project is to identify the determinants of antibody-mediated immunity in infants born to mothers immunized during pregnancy. Using maternal pertussis immunization as a model, the project will identify key predictors and potential determinants of vaccine responses in pregnant women, of the transfer of maternal antibodies to the newborn and of vaccine responses in infants. A systems biology approach will be used to delineate pre-vaccination and post-vaccination cellular and molecular correlates of the immune response to pertussis immunization in peripheral blood and in breastmilk.

NCT ID: NCT05856253 Completed - Clinical trials for ERAS Protocol, Esophagectomy

Enhanced Recovery in Esophageal Surgery

Start date: June 1, 2019
Phase:
Study type: Observational

Esophageal surgery remains the main treatment for esophageal cancer. Despite constant improvements, morbidity of esophagectomy remains high. For several years, enhanced rehabilitation programs have been used to reduce the impact of surgery on the patients to support a faster recovery. This study analyses the first results of newly implemented enhanced program after esophagectomy within the framework of an academic center.

NCT ID: NCT05855200 Recruiting - Colonic Neoplasms Clinical Trials

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

AZUR-2
Start date: August 2, 2023
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon cancer.

NCT ID: NCT05854277 Completed - Colorectal Cancer Clinical Trials

Inception, Validation and Clinical Utility of a Score to Assess the Completeness of Caecal Visualisation

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

CCIS is a novel score, created specifically to evaluate the completeness of caecal visualized. It can be applied to a single or multiple images. To create the CCIS, the caecum was divided into eight parts: the appendiceal orifice (AO), the tri-radiate fold part 1 (TF-1), 2 (TF-2), 3 (TF-3) and four outer quadrants (OQ 1-4). The ileo-caecal valve (ICV) is a reference point but is not part of the score. The quadrant adjacent to the ICV is labelled OQ1. The three other quadrants are labelled clockwise from this quadrant. The tri-radiate folds are also labelled clockwise with TF1 representing the triangle side that is majority-contained within OQ1. TF2 and TF3 are then labelled clockwise from TF1.

NCT ID: NCT05853419 Recruiting - Coronary Disease Clinical Trials

Change History and Adopt a Robotic SolutioN for anGioplasty procedurE

CHANGE
Start date: June 20, 2023
Phase:
Study type: Observational [Patient Registry]

The main objective of the CHANGE registry is the evaluation of the real-world performance and safety profile of the R-One System in PCI.

NCT ID: NCT05853328 Completed - BPPV Clinical Trials

Comparison of EM and SM+ Maneuvers in Patients With BPPV

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Objective of this prospective randomized treatment trial is to compare the effectiveness of the SemontPLUS (SM+) with the Epley maneuver (EM) for the therapy of posterior canal benign paroxysmal positional vertigo canalolithiasis (pcBPPV).

NCT ID: NCT05852431 Recruiting - Clinical trials for Severe Hypertriglyceridemia

To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

ENTRUST
Start date: June 15, 2023
Phase: Phase 3
Study type: Interventional

To determine the effect of Pegozafermin on fasting serum triglyceride levels in subjects with Severe Hypertriglyceridemia (TG ≥500 to ≤2000 mg/dL) after 26 weeks of treatment.

NCT ID: NCT05852340 Completed - Healthy Volunteers Clinical Trials

A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants

Start date: May 9, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare if two forms of study medicine, Ritlecitinib, get processed differently in healthy adults. This study is seeking participants who are: - aged 18 or older; - male or female who are healthy as determined by medical assessment ; - Body-mass Index (BMI) of 16 to 32, and a total body weight > 45kg. The study will take up to 2.5 months, including the screening period. There will be 5 periods in total for this study. Participants will have to stay at the study clinic for at least 11 days. Participants will take Riltecitinib either as sprinkled in Soft Food or as Intact Blend-In Capsule. On day 1 of each period, participants will take Riltecitinib and have blood samples taken both before and afterwards. Participants will also answer questions for taste assessment purpose. A follow-up phone call will be made at 28 to 35 days after the last study period.

NCT ID: NCT05851443 Recruiting - Clinical trials for Moderate to Severe Asthma

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Start date: July 11, 2023
Phase: Phase 2
Study type: Interventional

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

NCT ID: NCT05851196 Recruiting - Low Back Pain Clinical Trials

The Forgotten Role of Back Muscle Characteristics to Tailor Exercise Therapy for Recurrent Non-specific Low Back Pain

Back-to-Back
Start date: January 15, 2024
Phase:
Study type: Observational

Patients with non-specific low back pain will be compared to healthy, age- and sex-matched controls to determine the most discriminating back muscle characteristics and to delineate possible phenotypes of patients with non-specific low back pain showing impaired proprioceptive postural control. Additionally, the group of patients with non-specific low back pain will receive a 16-week, high-load proprioceptive training program. The effects of this training program on the different back muscle characteristics and proprioceptive postural control will be evaluated.